Oral 5-ASA Versus Prednisone in Short Term Treatment of Crohn's Disease: A Multicentre Controlled Trial

A multicencre randomized controlled trial was designed to compare the efficacy and safety of Eudragit-L coated oral 5-aminosalicylic acid (5-ASA) (Salofalk; lnterfalk) 3 g per day to a 'standard' oral prednisone therapeutic regimen in a 12 week treatment period of uncomplicated attacks of...

Full description

Saved in:
Bibliographic Details
Main Authors: F Martin, L Sutherland, IT Beck, AH Anderson, CN Williams, F Saibel, J Barrowman, S Lemire
Format: Article
Language:English
Published: Wiley 1990-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1990/659079
Tags: Add Tag
No Tags, Be the first to tag this record!